outcomes tend to cluster [8] . Though CAA can occur in any lobar region of the brain [6] , the posterior lobar regions seem more prone to severe vascular beta-amyloid depositions [6, 9] . Likewise, the resulting CAA-related ICH and cerebral microbleeds have primarily posterior lobar distributions, with the occipital lobe, in particular, exceptionally vulnerable to hemorrhagic outcomes [8, 10, 11] . Several elegant studies in CAA patients have provided strong evidence that microbleeds occur in areas of high loads of vascular amyloid [2, 4, 12] .
Aside from patient populations, microbleeds are frequently observed in seemingly asymptomatic, general population [13] [14] [15] [16] . The predominantly posterior distribution of lobar microbleeds has also been reported in these populations [13, 17] . However, the underlying pathologies of microbleeds in this group is still largely uncon rmed via amyloid imaging or autopsy, because these techniques are not widely available in the general population.
One case-control study of AD and preclinical-AD patients demonstrated that healthy controls with lobar cerebral microbleeds had significantly higher loads of beta-amyloid than those without lobar microbleeds [11] , and that incident lobar microbleeds in healthy controls are associated with both carriership of APOE e4 allele and higher load of beta-amyloid [18] . Moreover, the healthy controls who were e4 carriers had higher amyloid retention compared to those who were non-carriers [19] .
In a recent paper, posterior distribution of lobar microbleeds within the entire communitydwelling Rotterdam Study population was found, but those among this population, who were carriers of the APOE e2 or e4 alleles, had microbleeds that occurred closer together and had an ever higher proportion of microbleeds in the occipital lobe compared to persons with APOE e3e3 genotype [20] .
Though APOE e2 and e4 alleles are both associated with presence of CAA and risk of adverse outcomes due to CAA [21, 22] , each allele is associated with the pathology differently. Specifically, e4 allele is suggested to relate to CAA type 1, which includes amyloid depositions in the capillaries, whereas e2 allele is overrepresented among CAA type 2, which is devoid of amyloid depositions in the capillaries [23] . Moreover, the APOE e2 and e4 variants are thought to lead to hemorrhagic outcomes through different mechanisms. Studies in CAA and AD patients have shown that while the e4 allele carriers are shown to accumulate more beta-amyloid and faster, leading to a thickening and eventual rupture of vessel walls, e2 carriers are thought to have increased vessel fragility, leading to easier rupture of vessels without an increased amyloid burden compared to normal genotype [21, 22, [24] [25] [26] . Thus, these two alleles seem to result in distinct pathways, both of which are more susceptible to hemorrhagic outcomes compared to the wild-type genotype. The described posterior distribution of beta-amyloid deposition [6, 9] , lobar ICH [17, 20] . Our most recent work also showed that among all microbleeds, incident microbleeds occurred in close proximity to prevalent microbleeds within participants, particularly among APOE risk allele carriers [20] . Though the microbleeds in this analysis were primarily lobar, we did observe clustering between microbleeds that technically fell on opposite sides of regional boundaries, i.e., deep and lobar (Figure 1) [20] .
We can imagine that microbleeds that occur very close together share the same pathology 
